Vagi CL Tablet VT
By Vagi CL
Rx
7 Tablet VT in a Strip

Composition
Clindamycin(NA) + Metronidazole(NA) + Clotrimazole(NA)

Manufacturer - Rekvina Laboratories Ltd
328, Paradise Complex, Sayajigunj, Vadodara - 390005 ( Gujarat) INDIA.

Expires on or after
September, 2025

liver
In regards to liver safety, there have been no interactions found or established with the use of Vagi CL Tablet VT. It is important to be cautious and monitor any changes while taking this medication. If you have any concerns or pre-existing liver conditions, consult with your doctor before using Vagi CL Tablet VT. Your doctor can provide proper guidance tailored to your specific health needs.

kidney
No interaction with kidney issues has been found or established for Vagi CL Tablet VT.

alcohol
No interaction found between Vagi CL Tablet VT and alcohol. Always consult your doctor before consuming alcohol while taking this medication. Avoid during pregnancy.

driving
It is safe to drive while taking Vagi CL Tablet VT, as no interactions have been found.

pregnancy
Vagi CL Tablet VT is typically safe for use in pregnancy. Animal studies show minimal negative effects on the developing baby, but human studies are limited.

breastfeeding
Caution is advised when using Vagi CL Tablet VT during breastfeeding. It is recommended to refrain from breastfeeding until the treatment is finished and the drug is cleared from the body. If a single dose is taken, it's best to wait 12-24 hours before breastfeeding again.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹126
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024